Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1541
-
1542
-
1543
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”
-
1544
-
1545
(A) Decreased DNA CpG methylation at the CpG island of the gene locus in Th2 cells
Published 2011“…MeDIP assay was performed using an anti–5-methyl cytidine antibody (5-meC) and a control antibody (Cont.). …”
-
1546
-
1547
-
1548
Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum.
Published 2015“…In the contralateral (unlesioned) hemisphere (CL), no difference was seen in the proportion of axons in the corpus callosum that were myelinated in Scribble cKO compared to wild-type animals (A–C). Fewer remyelinated axons were observed in corpus callosum in the lesion area in Scribble cKO mice (E) relative to controls (D) as quantified in F; 0.4–0.5 μm: WT = 80.0% ± 9.8%, cKO = 41.3% ± 8.9% myelinated; 0.5–0.6 μm: WT = 79.4% ± 6.3%, cKO = 41.5% ± 9.5% myelinated; 0.6–0.7 μm: WT = 91.6% ± 3.0%, cKO = 44.3% ± 8.7% myelinated; >0.7 μm: WT = 92.7% ± 1.9%, cKO = 47.9% ± 2.5% myelinated. …”
-
1549
-
1550
-
1551
-
1552
-
1553
-
1554
-
1555
-
1556
-
1557
Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients
Published 2014“…We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state.</p><p>Results</p><p>The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients.…”
-
1558
CC genotype of rs7120118 variation associates with decreased soluble Aβ42 levels in the temporal cortex.
Published 2013“…<p>(A) The distribution of rs7120118 genotypes in subgroups divided by the severity of the disease (mild n = 19/18/9; moderate n = 4/4/5; severe n = 10/12/2, rs7120118 genotypes TT/CT/CC, respectively). …”
-
1559
-
1560